The phrase "adjunctive therapeutic" is correct and usable in written English.
It can be used in medical or clinical contexts to describe a treatment that is supplementary to a primary therapy.
Example: "The study focused on the adjunctive therapeutic effects of the new drug alongside standard treatment."
Alternatives: "supplementary treatment" or "additional therapy".
One can hypothesize that, if personality can be altered, it could serve as an adjunctive therapeutic option to the standard of care treatment especially when uveitis is not under control with maximum possible medications.
Thus, identifying this novel negative regulatory feedback loop involving RelB could be particularly useful as an adjunctive therapeutic approach for HAND, peripheral HIV infection, or even other neurologic or immune diseases, since overexpression of RelB in microglial cells does not completely block Tat-induced release of TNFα, which would negatively impact TNFα's other endogenous functions.
Other researchers have reported on the adjunctive therapeutic benefits of exercise in those on antidepressant therapy.
This should enable surgery or other adjunctive therapeutic regimens to be selected at an early stage.
Future studies will help determine the potential use of CHAC1 as an adjunctive therapeutic target for HNSCC.
Our findings support claims for S. frutescens being a promising adjunctive therapeutic for oxidative stress-related health problems.
Several observational studies suggested that statins could represent a useful therapeutic adjunctive modality, as a benefit of prior statin use was found in patients with pneumonia [51, 59, 63].
Interventions in metabolic remodeling therefore represent a promising therapeutic adjunctive for targeting pathological cardiac hypertrophy and development of heart failure (Ardehali et al, 2012).
Several observational studies suggested that statins could represent a useful therapeutic adjunctive modality, as a benefit of prior statin use was found in patients with pneumonia [ 51, 59, 63].
The findings presented here, demonstrating an 81% risk reduction in metachronous adenomas and >90% reduction in advanced adenomas among patients reporting less than the 75th percentile of dietary polyamine intake, suggest that controlling exogenous polyamines could be an adjunctive strategy to therapeutic prevention using polyamine-inhibitory agents.
In this 8-week study marked by significant therapeutic heterogeneity, adjunctive armodafinil 150 mg/day yielded a numerically greater, but not statistically significant, improvement on the primary efficacy outcome measure compared with placebo in treatment of bipolar I depression.
